(PTH) Invesco DWA Healthcare - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46137V8524 • Health
PTH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment
The Invesco DWA Healthcare Momentum ETF (NASDAQ:PTH) is designed to track the performance of companies in the healthcare sector exhibiting strong relative strength or momentum characteristics. The fund typically allocates at least 90% of its total assets to securities included in its underlying index, which is comprised of a minimum of 30 healthcare-related stocks. The index employs a momentum-based strategy, focusing on companies that demonstrate powerful price movement and relative strength compared to peers. This approach aims to capitalize on trending healthcare sectors, such as biotechnology, pharmaceuticals, and medical devices. For more information, visit http://www.invesco.com/us.
From a technical standpoint, PTH is currently trading below its key moving averages, with the 20-day SMA at 42.84 and the 50-day SMA at 41.84, both above the last price of 40.01. The 200-day SMA of 44.01 further indicates a downward trend. The Average True Range (ATR) of 1.06 reflects moderate volatility, while the average 20-day volume of 19,129 shares suggests limited trading activity. The funds assets under management (AUM) of $116.83 million indicate a modest but stable investor base.
Additional Sources for PTH ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PTH ETF Overview
Market Cap in USD | 114m |
Category | Health |
TER | 0.60% |
IPO / Inception | 2006-10-12 |
PTH ETF Ratings
Growth 5y | 9.98% |
Fundamental | - |
Dividend | 5.53% |
Rel. Strength Industry | -16.5 |
Analysts | - |
Fair Price Momentum | 33.25 USD |
Fair Price DCF | - |
PTH Dividends
Dividend Yield 12m | 0.06% |
Yield on Cost 5y | 0.10% |
Annual Growth 5y | % |
Payout Consistency | 14.2% |
PTH Growth Ratios
Growth Correlation 3m | -10% |
Growth Correlation 12m | 0.5% |
Growth Correlation 5y | -28.2% |
CAGR 5y | 10.49% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | 0.62 |
Alpha | -20.86 |
Beta | 1.29 |
Volatility | 34.76% |
Current Volume | 6.5k |
Average Volume 20d | 10k |
As of March 15, 2025, the stock is trading at USD 39.42 with a total of 6,462 shares traded.
Over the past week, the price has changed by +0.05%, over one month by -12.11%, over three months by -6.19% and over the past year by -8.29%.
Neither. Based on ValueRay Analyses, Invesco DWA Healthcare is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 9.98 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTH as of March 2025 is 33.25. This means that PTH is currently overvalued and has a potential downside of -15.65%.
Invesco DWA Healthcare has no consensus analysts rating.
According to ValueRays Forecast Model, PTH Invesco DWA Healthcare will be worth about 38.5 in March 2026. The stock is currently trading at 39.42. This means that the stock has a potential downside of -2.36%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 38.5 | -2.4% |